Bicaval cannulation for Atrial Fibrillation

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Atrial FibrillationBicaval cannulation - Other
Eligibility
18 - 100
All Sexes
What conditions do you have?
Select

Study Summary

This trial is a pilot RCT to study the efficacy of 2 types of venous cannulation during surgery for CABG in reducing the incidence of AF. 40 patients will be included, with 20 in each group. The primary endpoint is any episode of AF lasting >5 minutes or any episode leading to hemodynamic compromise or symptoms. Patients will be followed up at 1 month.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: During hospital admission and clinic visit at 30 days from hospital discharge date.

Day 30
Atrial fibrillation
Day 2
Increase in Left atrial index
Right ventricular dysfunction
Tricuspid regurgitation

Trial Safety

Safety Progress

1 of 3

Similar Trials

Trial Design

2 Treatment Groups

Cavoatrial cannulation
1 of 2
Bicaval cannulation
1 of 2

Active Control

Experimental Treatment

40 Total Participants · 2 Treatment Groups

Primary Treatment: Bicaval cannulation · No Placebo Group · N/A

Bicaval cannulation
Other
Experimental Group · 1 Intervention: Bicaval cannulation · Intervention Types: Other
Cavoatrial cannulation
Other
ActiveComparator Group · 1 Intervention: Cavoatrial cannulation · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: during hospital admission and clinic visit at 30 days from hospital discharge date.

Who is running the clinical trial?

Dr. Jean-Francois MorinLead Sponsor
Jean-François Morin, MD,FRCSCPrincipal InvestigatorJewish General Hospital

Eligibility Criteria

Age 18 - 100 · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References